e-learning
resources
Munich 2006
Sunday 03.09.2006
Epidemiology and treatment of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association of tuberculin sensitivity with the risk of tuberculosis development in dialysis patients
A. Christopoulos, A. Diamandopoulos, D. Gumenos, P. Demopulos, G. Barbalias (Patra, Greece)
Source:
Annual Congress 2006 - Epidemiology and treatment of tuberculosis
Session:
Epidemiology and treatment of tuberculosis
Session type:
Electronic Poster Discussion
Number:
1755
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Christopoulos, A. Diamandopoulos, D. Gumenos, P. Demopulos, G. Barbalias (Patra, Greece). Association of tuberculin sensitivity with the risk of tuberculosis development in dialysis patients. Eur Respir J 2006; 28: Suppl. 50, 1755
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Comparison of the QuantiFERON-TB and tuberculin skin test for detection of latent tuberculosis infection in cancer patients in a developing country
Source: ERJ Open Res, 5 (4) 00258-2018; 10.1183/23120541.00258-2018
Year: 2019
Comparison of the tuberculin skin test and the ELISPOT blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005
Comparison of Quanti-FERON-TB Gold and tuberculin skin test for diagnosis of latent tuberculosis infection in patients with chronic schizophrenia
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
Tuberculin hypersensitivity and its relation to nutritional status in patients with active pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010
Comparison of the tuberculin skin test and the RD1 elispot for the diagnosis of latent tuberculosis infection in renal transplant patients
Source: Eur Respir J 2006; 28: Suppl. 50, 142s
Year: 2006
Comparison between tuberculin skin testing and QuantiFERON Gold-In Tube for detection of latent tuberculosis in rheumatoid arthritis patients in a TB endemic population
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non- tuberculosis diseases
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Comparison of T-Spot.TB and tuberculin skin test among silicotic patients
Source: Eur Respir J 2008; 31: 266-272
Year: 2008
The prevalence of latent tuberculosis infection in a children social center: Comparison of QuantiFERON-TB Gold with tuberculin skin testing
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010
Concordance between tuberculin skin testing and interferon-gamma release assays in diagnosis of latent tuberculosis infection among HIV-infected individuals
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
Source: Eur Respir J 2016; 48: 1751-1763
Year: 2016
Performance of quantiferon assay and tuberculin skin test in end stage renal disease patients receiving hemodialysis
Source: Annual Congress 2010 - Tuberculosis in special populations
Year: 2010
Relationship between the whole blood interferon-gamma responses and the risk of active tuberculosis
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006
Comparison between quantiFERON-TB gold and tuberculin skin testing for the detection of tuberculosis infection among BCG vaccinated schoolers at risk for tuberculosis exposure
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Utility of tuberculin and anergy skin testing in predicting TB infection in HIV infected children in Constantza county
Source: Eur Respir J 2003; 22: Suppl. 45, 157s
Year: 2003
Impact of T-SPOT.
TB
test to exclude active
Mycobacterium tuberculosis
complex infection in patients with mycobacterial disease
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
Predictive value of a whole-blood IGRA for the development of active TB disease
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008
Contribution of the T-SPOT.TB assay for detection of latent tuberculous infection (LTBI) in contact tracing procedures
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006
Performance of the tuberculin skin test and Interferon-gamma release assays for detection of tuberculosis infection in immunocompromised patients in a TB endemic population
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
Indeterminate results of the quantiFERON®TB gold (QFT) in hospitalized patients at risk for MTB infection/disease
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept